Pharmacogenetics


DNA DRUG SENSITIVITY ASSESSMENT
DR. DAVID HOPPER, PH.D., FAABM, FAAMP, FAAS


Enhance drug treatment success!
Reduce harmful side effects!
Dramatically reduce emergency visits & hospital stays!
Reduce risk of overdose!
Reduce risk of adverse drug interaction!
Identify the safest medications to use!
Identify the most effective medications to use!


DNA drug sensitivity testing helps the healthcare provider identify the safest, most effective medications to use when treating patients who are at increased risk of medication-related problems. When there are problems achieving desired effects at recommended dosages, it is time to consider DNA drug sensitivity testing. When patients are taking multiple medications, it is time to consider DNA drug sensitivity testing. With chronic pain, patients are often prescribed a combination of opioids, NSAIDS, antidepressants, anxiolytics, hypnotics, and anti-hypertensives in addition to other medications. Additional medications are usually prescribed for cancer-related pain.

Genetic test results are often quite useful in getting pre-authorization for certain medications. Basic DNA testing may be performed for major drug metabolizing enzymes. The Comprehensive polypharmacy DNA test will assess the Basic major drug metabolizing enzymes and a wide variety of additional psychotropic, analgesic, cardiac, ADHD, and other important enzymes. Carriers of certain HLA polymorphisms are at risk for severe hypersensitivity when given certain medications, including abacavir, allopurinol, phenytoin and carbamazepine. An additional HLA test panel is available.

Only accredited labs are utilized. Buccal swabs are used. Laboratory findings are reported along with charts to aid the healthcare provider in easily providing more effective and safe treatment to patients. Call Dr. Hopper at (702) 528-0066 for more information and costs.


DR. DAVID HOPPER, PH.D., FAABM, FAAMP, FAAS
HOPPER INSTITUTE
4550 Oakey Blvd, Suite 103
Las Vegas, Nevada 89102
(702) 528-0066 / (702) 965-2565 FAX